Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Beaumont

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 31, 2022
ADME and DMPK considerations for the discovery and development of antibody drug conjugates (ADCs)Kevin Beaumont, Andy Pike, Michael Davies, et al.
Assay and Drug Development Technologies|April 20, 2004
Identification of signal transduction pathways used by orphan g protein-coupled receptorsJanine N Bresnick, Heather A Skynner, Kerry L Chapman, et al.
Journal of Medicinal Chemistry|November 8, 2007
Cyclization of the acyl glucuronide metabolite of a neutral endopeptidase inhibitor to an electrophilic glutarimide: synthesis, reactivity, and mechanistic analysisXiaoli Meng, James L Maggs, David C Pryde, et al.
Journal of Clinical Pharmacology|March 21, 2009
Prediction of human pharmacokinetics from preclinical information: comparative accuracy of quantitative prediction approachesNatilie A Hosea, Wendy T Collard, Susan Cole, et al.
American Journal of Hematology|April 23, 2021
PF-07059013: A non-covalent hemoglobin modulator favorably impacts disease state in a mouse model of sickle cell diseaseKelly M Knee, Reema Jasuja, Amey Barakat, et al.
Chemical Biology & Drug Design|February 24, 2006
The discovery of small molecule inhibitors of neutral endopeptidase. Structure-activity studies on functionalized glutaramidesGraham N Maw, Alan Stobie, Simon Planken, et al.
Pharmaceutical Research|January 19, 2024
Correction: Comparative Study of Dermal Pharmacokinetics Between Topical Drugs Using Open Flow Microperfusion in a Pig ModelManfred Bodenlenz, Thean Yeoh, Gabriel Berstein, et al.
Pharmaceutical Research|December 29, 2023
Comparative Study of Dermal Pharmacokinetics Between Topical Drugs Using Open Flow Microperfusion in a Pig ModelManfred Bodenlenz, Thean Yeoh, Gabriel Berstein, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 13, 2017
A cross-species translational pharmacokinetic-pharmacodynamic evaluation of core body temperature reduction by the TRPM8 blocker PF-05105679James R Gosset, Kevin Beaumont, Tomomi Matsuura, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 14, 2011
Case studies addressing human pharmacokinetic uncertainty using a combination of pharmacokinetic simulation and alternative first in human paradigmsAnthony Harrison, Iain Gardner, Tanya Hay, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 31, 2022
ADME and DMPK considerations for the discovery and development of antibody drug conjugates (ADCs)Kevin Beaumont, Andy Pike, Michael Davies, et al.
Assay and Drug Development Technologies|April 20, 2004
Identification of signal transduction pathways used by orphan g protein-coupled receptorsJanine N Bresnick, Heather A Skynner, Kerry L Chapman, et al.
Journal of Medicinal Chemistry|November 8, 2007
Cyclization of the acyl glucuronide metabolite of a neutral endopeptidase inhibitor to an electrophilic glutarimide: synthesis, reactivity, and mechanistic analysisXiaoli Meng, James L Maggs, David C Pryde, et al.
Journal of Clinical Pharmacology|March 21, 2009
Prediction of human pharmacokinetics from preclinical information: comparative accuracy of quantitative prediction approachesNatilie A Hosea, Wendy T Collard, Susan Cole, et al.
American Journal of Hematology|April 23, 2021
PF-07059013: A non-covalent hemoglobin modulator favorably impacts disease state in a mouse model of sickle cell diseaseKelly M Knee, Reema Jasuja, Amey Barakat, et al.
Chemical Biology & Drug Design|February 24, 2006
The discovery of small molecule inhibitors of neutral endopeptidase. Structure-activity studies on functionalized glutaramidesGraham N Maw, Alan Stobie, Simon Planken, et al.
Pharmaceutical Research|January 19, 2024
Correction: Comparative Study of Dermal Pharmacokinetics Between Topical Drugs Using Open Flow Microperfusion in a Pig ModelManfred Bodenlenz, Thean Yeoh, Gabriel Berstein, et al.
Pharmaceutical Research|December 29, 2023
Comparative Study of Dermal Pharmacokinetics Between Topical Drugs Using Open Flow Microperfusion in a Pig ModelManfred Bodenlenz, Thean Yeoh, Gabriel Berstein, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 13, 2017
A cross-species translational pharmacokinetic-pharmacodynamic evaluation of core body temperature reduction by the TRPM8 blocker PF-05105679James R Gosset, Kevin Beaumont, Tomomi Matsuura, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 14, 2011
Case studies addressing human pharmacokinetic uncertainty using a combination of pharmacokinetic simulation and alternative first in human paradigmsAnthony Harrison, Iain Gardner, Tanya Hay, et al.
Pageof 5